Therapy Professions

Catalog

Browse eligible courses by profession.

Filter by
5 courses Catalog: Therapy Professions
Type: OnlineCourse Code: 20-1313828 Duration: 0 minutes

Online course 0 hours

Hours
0 hours
Code
20-1313828
Duration
0 minutes
Course Description: This course discusses addiction by defining key terms, differentiating between various substance use disorders, and outlining diagnostic criteria. It also covers the risks associated with opioid medications, patient evaluation techniques, and compares treatment options such as methadone, buprenorphine, and naltrexone. Upon completion, participants will be...

This course meets the Kentucky APRN Requirements

Contact Hour(s): 

 2.5 Contact hours, including 2.5 Advanced Pharmacology Hours

Author:

Raymond Lengel, MSN, FNP-BC, RN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

CEUFast, Inc. is an AOTA Provider of professional development. PD activity approval ID# 14031. This distant learning-independent activity is offered at 0.025 CEUs, Intermediate, Categories: OT Service Delivery, Foundational Knowledge. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures.

State Approvals:

  • Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1313828; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses addiction by defining key terms, differentiating between various substance use disorders, and outlining diagnostic criteria. It also covers the risks associated with opioid medications, patient evaluation techniques, and compares treatment options such as methadone, buprenorphine, and naltrexone. Upon completion, participants will be better equipped to assess and manage addiction disorders in clinical settings. This course meets the Kentucky APRN Requirements. 

Outcomes:

≥ 92% of participants will know how to assess and manage addiction.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Define addiction and other terms associated with substance abuse.
  2. Compare and contrast substance use disorder (SUD), opioid use disorder (OUD), alcohol use disorder (AUD), and cannabis use disorder (CUD).
  3. Describe the risks of abuse and addiction to opioid medications.
  4. Summarize the evaluation of a patient with a SUD.
  5. Compare and contrast the use of methadone, buprenorphine, and naltrexone in the management of OUD.
  6. Identify five professional standards of 201 KAR 20:065 for prescribing Buprenorphine-monoproduct or Buprenorphine/Naloxone.

 Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Type: OnlineCourse Code: 20-650617 Duration: 0 minutes

Online course 1 Contact hours

Hours
1 Contact hours
Code
20-650617
Duration
0 minutes
Course Description: This course discusses the microvascular complications of diabetes. Specific microvascular complications, including diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy, are outlined. The epidemiology, pathophysiology, risk factors, signs/symptoms, treatment, and prevention of these complications are discussed.Outcomes ≥ 92% of participants ...

Contact Hour(s): 

1 Contact Hour including 1 Pharmacology Hour

Author:

Dana Bartlett, RN, BSN, MA, MA, CSPI

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN)

Accreditations:

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-650617; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description: 

This course discusses the microvascular complications of diabetes. Specific microvascular complications, including diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy, are outlined. The epidemiology, pathophysiology, risk factors, signs/symptoms, treatment, and prevention of these complications are discussed.

Outcomes 

≥ 92% of participants will know the microvascular complications of diabetes, and the signs/symptoms, risk factors, and treatments for these complications.

Objectives 

After completing this module, the learner will be able to:

  1. Summarize the microvascular complications of diabetes.
  2. Identify risk factors associated with developing diabetic microvascular complications.
  3. Evaluate screening and diagnosis methods of diabetic microvascular complications.
  4. Outline interventions used to treat diabetic microvascular complications.
  5. Paraphrase prevention methods of diabetic microvascular complications.

Disclosures: 

 CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Type: OnlineCourse Code: 20-1359428 Duration: 0 minutes

Online course 1 Contact hours

Hours
1 Contact hours
Code
20-1359428
Duration
0 minutes
Course Description: This course discusses the use of ketamine, a drug classified by the Drug Enforcement Administration (DEA) as a Schedule III drug with moderate abuse potential, as a viable treatment option for treatment-resistant depression, as well as the legal and ethical challenges that come with using controlled substances. Outcomes ≥ 92% of participants will know abo...

Contact Hour(s):  

1 Contact Hour including 1 Pharmacology Hour 

Author

Heather Rhodes (APRN-BC) 

This peer-reviewed course is applicable for the following professions

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner, Respiratory Therapist (RT) 

Accreditations:  

The American Nurses Credentialing Center (ANCC), Board of Certification for Athletic Trainers (BOC)  

State Approvals:  

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy   

Course Description

This course discusses the use of ketamine, a drug classified by the Drug Enforcement Administration (DEA) as a Schedule III drug with moderate abuse potential, as a viable treatment option for treatment-resistant depression, as well as the legal and ethical challenges that come with using controlled substances. 

Outcomes 

≥ 92% of participants will know about the use of ketamine to treat treatment-resistant depression. 

Objectives 

After completing this continuing education course, the participant will be able to meet the following objectives: 

  1. Recognize the defining features of treatment-resistant depression as per the DSM-5. 
  2. Identify two exclusionary criteria for ketamine treatment in patients who have treatment-resistant depression. 
  3. Determine the side effects of ketamine to monitor for after administration. 
  4. Identify two symptoms of “K-hole’ a patient may experience after ketamine administration. 
  5. Summarize ethical considerations with the use of ketamine. 

Disclosures

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 




Type: OnlineCourse Code: 20-1239158 Duration: 0 minutes

Online course 2 Contact hours

Hours
2 Contact hours
Code
20-1239158
Duration
0 minutes
Course Description: This course discusses the multifactorial etiology, risk factors, comorbid conditions, treatment, and nursing care of pediatric patients diagnosed with obesity.

Contact Hour(s): 

2 Contact Hours, including 2 Pharmacology Hours

Author:

Sarah Beattie, DNP, APRN-CNP, CDCES

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner, Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

CEUFast, Inc. is an AOTA Provider of professional development.  PD activity approval ID#11254.  This distant learning-independent activity is offered at 0.2 CEUs Intermediate, Categories: OT Service Delivery, Foundational Knowledge.  The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures.

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1239158; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses the multifactorial etiology, risk factors, comorbid conditions, treatment, and nursing care of pediatric patients diagnosed with obesity.

Outcomes:

≥ 92% of participants will know how to care for pediatric patients diagnosed with obesity.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Define the diagnostic criteria for pediatric obesity.
  2. Identify risk factors for pediatric obesity.
  3. Specify three comorbid conditions related to obesity.
  4. Describe the socioeconomic impact on pediatric obesity.
  5. Summarize the healthcare professional's role in combating pediatric obesity.
  6. Explain the treatment options available for treating pediatric obesity.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Type: OnlineCourse Code: 20-1251582 Duration: 0 minutes

Online course 3 Contact hours

Hours
3 Contact hours
Code
20-1251582
Duration
0 minutes
Course Description: The course will provide an overview of pharmacology, raise awareness and understanding of the various aspects of pharmacology, and increase the nurse's knowledge base.

Contact Hour(s): 

3 Contact Hours, including 3 Advanced Pharmacology Hours

Author:

Raymond Lengel, MSN, FNP-BC, RN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA)

CEUFast, Inc. is an AOTA Provider of professional development.  PD activity approval ID# 11360. This distant learning-independent activity is offered at 0.3 CEUs Intermediate, Categories: Professional Issues, Foundational Knowledge.  The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures.

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1251582; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy

Course Description:

The course will provide an overview of pharmacology, raise awareness and understanding of the various aspects of pharmacology, and increase the nurse's knowledge base.

Outcomes:

≥ 92% of participants will improve their knowledge of pharmacology and knowledge related to medication management.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Relate the ten rules that serve as the standard for legal accountability in drug administration.
  2. Outline common principles of pharmacokinetics.
  3. Identify the types of patients who require special consideration when administering drugs.
  4. Summarize the role of drugs and therapeutic devices in preventing disease and maintaining health.
  5. Specify the indications and adverse effects of major categories of drugs.
  6. List common agents included in each category of drugs.
  7. Identify nursing considerations for each category of drug.
  8. Describe common drug errors that are avoidable and strategies to avoid them.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.